Plant Impact plc Signs R&D Collaboration Agreement with CEMAS and tecsolve Ltd
News Jun 23, 2009
Plant Impact has announces that as part of an ongoing strategic review of its activities, and in light of the successful completion of the commercialization deal with Arysta Life Science Corporation (Arysta), it has signed long term agreements with tecsolve and CEMAS (Agreements).
The Agreements, which are effective as of 1 June 2009, provide for the retention of the services of CEMAS and tecsolve by Plant Impact.
Under the terms of the Agreements Plant Impact may engage CEMAS to assist with the development of the Company’s growing pipeline of products that have been developed to improve crop yields in an eco-friendly manner and tecsolve to assist with product discovery, technological appraisal and technical advice.
The executives of Plant Impact recognized early on that they would need to make significant investments in infrastructure and employ a much larger team if they were to run all the additional trials required to generate supporting data on their products. This information has to be supplied to both the regulatory bodies and the global players that will ultimately commercialize their products.
As a result, Plant Impact has reviewed its options in respect of the need to generate more data and consequently, the executives have agreed to outsource further development of Plant Impact’s products to well established and respected specialist contract research organizations, and have therefore finalized these long term Agreements with CEMAS and tecsolve.
“At Plant Impact, we possess great understanding of the biology of plant growth and the protection mechanisms that plants use against pathogens and pest infestations.” commented Peter Blezard, CEO of Plant Impact. “We are also commercially orientated as evidenced by the increasing number of initial shipments we have made of our products to new customers and the global deal with Arysta on BugOil®.”
CEMAS/tecsolve were heavily involved in the development of BugOil® and the relationship between the companies has been productive for all parties over the past 6 years. As a result, it was decided by Plant Impact that they would outsource discovery activities to tecsolve and development activities to CEMAS and concentrate their efforts on commercialization.
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.
Therapeutic CRISPR Could Be Cancer RiskNews
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.